Surface Oncology CEO J Goater's 2019 pay falls 65% to $1.6M
Surface Oncology reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Surface Oncology reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, three executives at Surface Oncology received on average a compensation package of $1.1M, a 51% decrease compared to previous year.
Average pay of disclosed executives at Surface Oncology
J. Jeffrey Goater, Chief Executive Officer, received $1.6M in total, which decreased by 65% compared to 2018. 53% of Goater's compensation, or $867K, was in option awards. Goater also received $255K in non-equity incentive plan, $510K in salary, as well as $10K in other compensation.
Vito J. Palombella, Chief Scientific Officer, received a compensation package of $811K, which decreased by 17% compared to previous year. 49% of the compensation package, or $400K, was in salary.
Robert W. Ross, Chief Medical Officer, earned $810K in 2019, a 8% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2020.